Research Project News and Research

RSS

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

6 Nov 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.

6 Nov 2009

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.

4 Nov 2009

NIH grant to NC State researchers to study how nanomaterials interact with biological systems

Tiny, engineered nanomaterials can already be found in many consumer products, and have been hailed as having widespread future uses in areas ranging from medicine to industrial processes. However, little is known about what happens if these nanomaterials get into your body - where do they go? NC State researchers are working to answer that question under a grant from the National Institutes of Health (NIH).

4 Nov 2009

Malaria Conference addresses RTS,S vaccine, tools, treatment

On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, scientists and global health experts focused on malaria eradication, Agence France-Presse reports. "Key among the strategies ... is the development of an effective anti-malaria vaccine, a project scientists have been researching since the late 80s. ... RTS,S is the most clinically advanced malaria vaccine so far, according to the Malaria Vaccine Initiative," the news service writes (11/3).

3 Nov 2009

ACTwatch data indicates low accessibility of artemisinin combination therapy

ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk.

2 Nov 2009

Shire announces third quarter 2009 financial results

Shire plc, the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009.

31 Oct 2009

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest.

31 Oct 2009

FPB to develop research tools and strategies to include disabled people in future research

While the public has made accommodations for 54.4 million people with disabilities, many researchers regularly exclude people who cannot read, hear or write from participating in their research projects.

30 Oct 2009

Research project to improve early diagnosis and treatment of mild traumatic brain injuries

With financial backing from a leading nonprofit supporter of military medical research, medical device manufacturer Neuro Kinetics, Inc. (www.neuro-kinetics.com) said today that it is collaborating with the U.S. Army Aeromedical Research Laboratory (USAARL) at Fort Rucker, Alabama, and three other military medical facilities in a comprehensive research project to improve early diagnosis and treatment of mild traumatic brain injuries (mTBI).

30 Oct 2009

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

Sangamo BioSciences, Inc. announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells.

29 Oct 2009

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

NCKU President, Academician Michael Ming-Chiao Lai, signed Technology Transfer Agreement in this morning with Mr. Tou-Hsiung Yang, Chairman of Vedan International (Holding) Ltd, witnessed by Vedan Biotechnology President Shih-An (Raymond) Yang and the inventor, Prof. Huey-Lang Yang of the NCKU Institute of Biotechnology.

28 Oct 2009

NIH awards The Tufts CTSI and Tufts University four supplemental grants

The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.

27 Oct 2009

National Cancer Institute awards Johns Hopkins $14.8 million for cancer research

Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.

26 Oct 2009

Novel protein responsible for changing DNA structure and silencing the expression of genes identified

A study published recently in the Proceedings of the National Academy of Science (PNAS) by a team of scientists headed by Professors Hélène Bierne and Pascale Cossart from the Pasteur Institute, in collaboration with colleagues form the CNRS and the French Agricultural Research Institute (INRA), identified a novel protein, BAHD1, which is responsible for changing DNA structure and silencing the expression of genes.

26 Oct 2009

APC enzyme may be effective for treating amyotrophic lateral sclerosis

A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. The results offer a bit of good news in efforts to develop a therapy to stop or slow the progression of a disease that generally kills its victims within just a few years.

26 Oct 2009

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

Researchers from Allegheny General Hospital's (AGH) Department of Orthopaedic Surgery and Center for Genomic Sciences have launched dual groundbreaking studies that may help determine the cause of two common, hard-to-treat problems experienced by patients who undergo orthopedic surgery: a joint replacement that becomes infected and a bone fracture that will not heal properly.

24 Oct 2009

NIH awards $1.4 million Small Business Technology Transfer grant to BloodCenter of Wisconsin

BloodCenter of Wisconsin (BCW) today announced that the National Institutes of Health (NIH) has awarded a $1.4 million Small Business Technology Transfer grant to fund continued research into the deployment of Radio Frequency Identification (RFID) technology to enhance safety and reduce hospital costs related to the collection, manufacture and transfusion of blood products. The NIH grant allows the first-ever research into the potential clinical and financial benefits of RFID technology for automatic identification, tracking, and status monitoring of blood and blood products across the entire transfusion medicine supply chain.

24 Oct 2009

University researchers inject 'nanowires' in rat brains

The biological safety of nanotechnology, in other words, how the body reacts to nanoparticles, is a hot topic. Researchers at Lund University in Sweden have managed for the first time to carry out successful experiments involving the injection of so-called 'nanowires.'

23 Oct 2009

Exposing pregnant women to chemotherapy does not affect the foetus

Professor Frederic Amant of the Katholieke Universiteit Leuven (K.U.Leuven) directs research into the treatment of cancer in pregnant women and the consequences of such treatment on foetal development. In her PhD dissertation on chemotherapy during pregnancy, Kristel Van Calsteren presents new scientific discoveries.

23 Oct 2009

Research Project News and Research

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

NIH grant to NC State researchers to study how nanomaterials interact with biological systems

Malaria Conference addresses RTS,S vaccine, tools, treatment

ACTwatch data indicates low accessibility of artemisinin combination therapy

Shire announces third quarter 2009 financial results

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

FPB to develop research tools and strategies to include disabled people in future research

Research project to improve early diagnosis and treatment of mild traumatic brain injuries

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

NIH awards The Tufts CTSI and Tufts University four supplemental grants

National Cancer Institute awards Johns Hopkins $14.8 million for cancer research

Novel protein responsible for changing DNA structure and silencing the expression of genes identified

APC enzyme may be effective for treating amyotrophic lateral sclerosis

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

NIH awards $1.4 million Small Business Technology Transfer grant to BloodCenter of Wisconsin

University researchers inject 'nanowires' in rat brains

Exposing pregnant women to chemotherapy does not affect the foetus

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News